Site-specific mutagenicity of stereochemically defined 1, N 2-deoxyguanosine adducts of trans-4-hydroxynonenal in mammalian cells

Environmental and Molecular Mutagenesis

Volumn 42, Issue 2, 2003, Pages 68-74

  Fernandes, Priscilla H ^a   Wang, Hao ^b   Rizzo, Carmelo J ^b   Lloyd, R Stephen ^a  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

HNE dG adducts; Mutagenicity; Stereoisomers; Trans 4 hydrononenal

Indexed keywords

4 HYDROXYNONENAL; DEOXYGUANOSINE DERIVATIVE; NUCLEIC ACID; OLIGODEOXYNUCLEOTIDE; PROTEIN;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CELL STRAIN COS7; CHEMICAL STRUCTURE; CONTROLLED STUDY; DNA VECTOR; GENE MUTATION; LIPID PEROXIDATION; MAMMAL CELL; MUTAGENESIS; MUTAGENICITY; NONHUMAN; SITE DIRECTED MUTAGENESIS; STEREOCHEMISTRY; STEREOISOMERISM; SYNTHESIS;

ALDEHYDES; ANIMALS; COS CELLS; CRICETINAE; DEOXYGUANOSINE; DNA ADDUCTS; MUTAGENESIS, SITE-DIRECTED; STEREOISOMERISM;

MAMMALIA; UNIDENTIFIED SHUTTLE VECTOR;

EID: 0041639695     PISSN: 08936692     EISSN: None     Source Type: Journal    
DOI: 10.1002/em.10174     Document Type: Article

References (35)

1. Alary J, Bravais F, Cravedi JP, Debrauwer L, Rao D, Bories G. 1995. Mercapturic acid conjugates as urinary end metabolites of the lipid peroxidation product 4-hydroxy-2-nonenal in the rat. Chem Res Toxicol 8:34-39.
2. Alary J, Debrauwer L, Fernandez Y. Cravedi JP, Rao D, Bories G. 1998. 1,4-Dihydroxynonene mercapturic acid, the major end metabolite of exogenous 4-hydroxy-2-nonenal, is a physiological component of rat and human urine. Chem Res Toxicol 11:130-135.
3. Bartsch H, Nair J, Owen RW. 1999. Dietary polyunsaturated fatty acids and cancers of the breast and colorectum: emerging evidence for their role as risk modifiers. Carcinogenesis 20:2209-2218.
4. Bolt HM. 1988. Roles of etheno adducts in tumorigenesis of olefins. CRC Crit Rev Toxicol 18: 299-309.
5. Bolt HM. 1994. Vinyl halides, haloaldehydes and monoalkanes. IARC Sci Publ 125:141-150.
6. Cajelli E, Ferraris A, Brambilla G. 1987. Mutagenicity of 4-hydroxynonenal in V79 Chinese hamster cells. Mutat Res 190:169-171.
7. Chen HJ, Chung FL. 1994. Formation of etheno adducts in reactions of enals via autoxidation. Chem Res Toxicol 7: 857-860.
8. Chung FL, Nath RG, Ocando J, Nishikawa A, Zhang L. 2000. Deoxyguanosine adducts of t-4-hydroxy-2-nonenal are endogenous DNA lesions in rodents ard humans: detection and potential sources. Cancer Res 60:1507-1511.
9. 2-propano-2′-deoxyguanosine. J Biol Chem 276:9077-9082.
10. Esterbauer H, Schaur RJ, Zollner H. 1991.Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 11:81-128.
11. 2-propalodeoxyguanosine adducts of trans-4-hydroxy-2-nonenal in Alzheimer's disease. Neurosci Lett 324:49-52.
12. Hirt B. 1967. Selective extraction of polyoma DNA from infected mouse cell cultures. J Mol Biol 26:365-369.
13. Hu W, Feng Z, Eveleigh J, Iyer G, Pan J, Amin S, Chung FL, Tang MS. 2002. The major lipid peroxidation product, trans-4-hydroxy-2-nonenal, preferentially forms DNA adducts at codon 249 of human p53 gene, a unique mutational hotspot in hepatocellular carcinoma. Carcinogenesis 23:1781-1789.
14. Hussain SP, Raja K, Amstad PA, Sawyer M, Trudel LJ, Wogan GN, Hofseth LJ, Shields PG, Billiar TR, Trautwein C, Hohler T, Galle PR, Phillips DH, Markin R, Marrogi AJ, Harris CC. 2000. Increased p53 mutation load in non-tumorous human liver of Wilson disease and hemochromatosis: oxyradical overload diseases. Proc Natl Acad Sci USA 97:12770-12775.
15. Kanuri M, Minko IG, Nechev LV, Harris TM, Harris CM, Lloyd RS. 2002. Error prone translesion synthesis past gamma-hydroxypropano deoxyguanosine, the primary acrolein-derived adduct in mammalian cells. J Biol Chem 277:18257-18265.
16. Kozekov ID, Nechev LV, Moseley MS, Harris CM, Rizzo CJ, Stone MP, Harris TM. 2003. DNA interchain cross-links formed by acrolein and crotonaldehyde. J Am Chem Soc 125:50-61.
17. Kurtz AJ, Lloyd RS. 2003. 1,N2-Deoxyguanosine adducts of acrolein, crotonaldehyde, and trans-4-hydroxynonenal cross-link to peptides via Schiff base linkage. J Biol Chem 278:5970-5976.
18. Moriya M. 1993. Single-stranded shuttle phagemid for mutagenesis studies in mammalian cells: 8-oxoguanine in DNA induces targeted GC→TA transversions in simian kidney cells. Proc Natl Acad Sci USA 90:1122-1126.
19. Napoli C, D'Armiento FP, Mancini FP, Postiglione A, Witztum JL, Palumbo G, Palinski W. 1997. Fatty streak formation occurs in human foetal aortas and is greatly enhanced by maternal hypercholesterolemia. Intimal accumulation of low-density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions. J Clin Invest 100:2680-2690.
20. Nechev LV, Harris CM, Harris TM. 2000. Synthesis of nucleosides and oligonucleotides containing adducts of acrolein and vinyl chloride. Chem Res Toxicol 13:421-429.
21. Nechev LV, Kozekov I, Harris CM, Harris TM. 2001. Stereospecific synthesis of oligonucleotides containing crotonaldehyde adducts of deoxyguanosine. Chem Res Toxicol 14:1506-1512.
22. Parola M, Bellomo G, Robino G, Barrera G, Dianzani MU. 1999. 4-Hydroxynonenal as a biological signal: molecular basis and pathophysiological implications. Antioxid Redox Signal 1:255-284.
23. Poli G, Schaur RJ. 2000. 4-Hydroxynonenal in the pathomechanisms of oxidative stress. IUBMB Life 50:315-321.
24. Sanchez AM, Minko IG, Kurtz AJ, Kanuri M, Moriya M, Lloyd RS. 2003. Comparative evaluation of the bioreactivity and mutagenic spectra of acrolein-derived α-HOPdG and γ-HOPdG regioisomeric deoxyguanosine adducts. Chem Res Toxicol, in press.
25. Sayre LM, Zelasko DA, Harris PL, Perry G, Salomon RG, Smith MA. 1997. 4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease. J Neurochem 68: 2092-2097.
26. Schneider C, Tallman KA, Porter NA, Brash AR. 2001. Two distinct pathways of formation of 4-hydroxynonenal. Mechanisms of non-enzymatic transformation of the 9- and 13-hydroperoxides of linoleic acid to 4-hydroxyalkenals. J Biol Chem 276:20831-20838.
27. Sodum RS, Chung FL. 1989. Structural characterization of adducts formed in the reaction of 2,3-epoxy-4-hydroxynonenal with deoxyguanosine. Chem Res Toxicol 2:23-28.
28. 2-propanodeoxyguanosine adducts of trans-4-hydroxy-2-nonenal after gavage of trans-4-hydroxy-2-nonenal or induction of lipid peroxidation with carbon tetrachloride in F344 rats. Chem Biol Interact 137:269-283
29. 2-deoxyguanosine adducts of the lipid peroxidation product trans-4-hydroxynonenal. Org Lett 3:3603-3605.
30. Wang H, Kozekov, ID, Harris TM, Rizzo CJ. 2003. Site-specific synthesis and reactivity of oligonucleotides containing stereochemically defined 1,N2-deoxyguanosine adducts of the lipid peroxidation product trans-4-hydroxynonenal. J Am Chem Soc 125:5687-5700
31. Winter CK, Segall HJ, Haddon WF. 1986. Formation of cyclic adducts of deoxyguanosine with the aldehydes trans-4-hydroxy-2-hexenal and trans-4-hydroxy-2-nonenal in vitro. Cancer Res 46:5682-5686.
32. Yamagami K, Yamamoto Y, Kume M, Ishikawa Y, Yamaoka Y, Hiai H, Toyokuni S. 2000. Formation of 8-hydroxy-2′-deoxyguanosine and 4-hydroxy-2-nonenal modified proteins in rat liver after ischemia-reperfusion: distinct localization of the two oxidatively modified proteins. Antioxid Redox Signal 2:127-136.
33. Yang IY, Chan G, Miller H, Huang Y, Torres MC, Johnson F, Moriya M. 2002. Mutagenesis by acrolein-derived propanodeoxyguanosine adducts in human cells. Biochemistry 41:13826-13832.
34. 2-(1,3-propano)-2′-deoxyguanosine 3′-phosphate adducts formed from 4-hydroxy-2-nonenal. Chem Res Toxicol 10:1259-1265.
35. Yoritaka A, Hattori N, Uchida K, Tanaka M, Stadtman ER, Mizuno Y. 1996. Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease. Proc Natl Acad Sci USA 93:2696-2701.